藥品福利管理市場規模、佔有率和成長分析:按服務、經營模式、最終用戶和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2035529

藥品福利管理市場規模、佔有率和成長分析:按服務、經營模式、最終用戶和地區分類-2026-2033年產業預測

Pharmacy Benefit Management Market Size, Share, and Growth Analysis, By Services (Pharmacy Services, Drug Management), By Business Models (Pharmacy Benefit Management, Employer Programs), By End Users, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球藥品福利管理 (PBM) 市場價值為 32 億美元,預計到 2025 年將成長至 33.5 億美元,到 2033 年將成長至 48 億美元,預測期(2026-2033 年)的複合年成長率為 4.6%。

藥品福利管理(PBM)是一個至關重要的系統,其中第三方管理機構代表包括健康保險公司和藥房在內的各相關人員管理處方藥項目。 PBM 在藥品供應鏈中扮演著至關重要的角色,資金籌措、監督配藥政策、協商藥品回扣、管理學名藥過渡以及處方藥目錄(藥品目錄)策略。其服務範圍廣泛,涵蓋從專業藥房支援到疾病管理和福利計劃設計等各個方面。受減少用藥錯誤需求不斷成長、人口老化和人事費用上升等因素的推動,預計該市場將顯著成長。然而,藥房不願採用自動化以及嚴格的保密規定等挑戰可能會阻礙其發展。儘管如此,人們對成本管理策略日益成長的認知為市場擴張帶來了可觀的機會。

全球藥局福利管理市場的成長要素

全球慢性病發生率的上升顯著推高了對有效治療方法的需求。為此,大型製藥公司正投入大量資源研發價格昂貴的品牌藥,旨在控制這些慢性病。這種對高成本治療的關注導致藥品價格大幅上漲。此外,包括心血管疾病和呼吸系統疾病在內的各種慢性病處方箋的顯著增加,進一步推高了整體醫療保健成本。在這種動態環境下,藥品福利管理在應對不斷飆升的醫療成本方面發揮著至關重要的作用。

全球藥品福利管理市場的限制因素

由於藥品支出不斷成長以及全球處方箋激增,全球藥品福利管理市場正在蓬勃發展。儘管呈現上升趨勢,但圍繞經營模式的透明度問題仍然是藥品福利管理領域的重要關注點。相關人員日益認知到這些服務需要透明度和課責,而這可能會阻礙市場成長。解決這些透明度挑戰對於建立消費者和醫療服務提供者之間的信任至關重要,並將最終影響藥品福利管理的整體格局。為了市場的永續發展,平衡業務擴張與透明營運實踐的需求至關重要。

全球藥品福利管理市場趨勢

全球藥品福利管理 (PBM) 市場正經歷著向機器學習技術融合的顯著轉變,這大大提升了營運效率和服務交付水準。隨著保險公司、零售藥局連鎖和製藥廠商擴大採用 PBM 服務,供應商正從傳統的工作流程轉向高度自動化的流程。這種轉型簡化了供應鏈,加快了郵購銷售速度,使企業能夠更快地服務更廣泛的客戶群。機器學習的應用增強了決策能力,最佳化了成本管理,並最終提高了醫療服務質量,使 PBM 成為不斷發展的製藥行業中不可或缺的重要組成部分。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球藥品福利管理市場規模:依服務分類

  • 藥局服務
    • 專科藥房
    • 郵購藥房
    • 零售藥房
    • 其他服務
  • 藥物管理
    • 藥物處方管理
    • 設計福利計劃

全球藥品福利管理市場規模:依經營模式分類

  • 藥品福利管理
    • PBM機構
  • 雇主計劃
    • 雇主贊助的項目
  • 政府項目
    • 政府健康計劃

全球藥品福利管理市場規模:依最終用戶分類

  • 醫療服務提供方
  • 消費者
  • 其他最終用戶

全球藥品福利管理市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Express Scripts Holding Company
  • CVS Health Corporation
  • OptumRx, Inc.
  • Prime Therapeutics LLC
  • Humana Pharmacy Solutions, Inc.
  • MedImpact Healthcare Systems, Inc.
  • Cigna Corporation
  • Aetna Inc.
  • Anthem, Inc.
  • UnitedHealth Group Incorporated
  • WellDyneRx, LLC
  • Navitus Health Solutions, LLC
  • PerformRx, LLC
  • IngenioRx, Inc.
  • Magellan Health, Inc.
  • Argus Health Systems, Inc.
  • ScriptCare, Ltd.
  • Catalyst Rx, Inc.
  • Curascript Specialty Distribution, Inc.
  • Pharmacy Benefit Dimensions, Inc.

結論與建議

簡介目錄
Product Code: SQMIG45I2098

Global Pharmacy Benefit Management Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.35 Billion in 2025 to USD 4.8 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

Pharmacy Benefit Management (PBM) is a vital system whereby third-party administrators manage prescription drug programs on behalf of various stakeholders, including health insurers and pharmacies. PBMs play a significant role in the pharmaceutical supply chain by overseeing financing, dispensing policies, and negotiating drug rebates, while also managing generic drug replacements and formulary strategies. Their extensive services range from specialized pharmacy support to disease management and benefit plan design. The market is poised for notable growth driven by rising demands to minimize medication errors, an aging population, and increasing labor costs. However, challenges such as reluctance to adopt pharmacy automation and stringent confidentiality regulations may hinder progress. Yet, growing awareness around cost-management strategies presents promising opportunities for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacy Benefit Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacy Benefit Management Market Segments Analysis

Global Pharmacy Benefit Management Market is segmented by Services, Business Models, End Users and region. Based on Services, the market is segmented into Pharmacy Services and Drug Management. Based on Business Models, the market is segmented into Pharmacy Benefit Management, Employer Programs and Government Programs. Based on End Users, the market is segmented into Healthcare Providers, Consumers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmacy Benefit Management Market

The growing incidence of chronic illnesses worldwide is significantly boosting the demand for effective treatment options. In response, major pharmaceutical companies are directing their resources towards the development of expensive branded medications aimed at managing these chronic conditions. This emphasis on high-cost therapies has led to a notable escalation in pharmaceutical expenditures. Additionally, there has been a marked rise in the issuance of prescriptions for various chronic ailments, including cardiovascular diseases and respiratory disorders, further contributing to the overall increase in healthcare expenses. This dynamic environment underscores the critical role of pharmacy benefit management in navigating these rising costs.

Restraints in the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management market is experiencing growth due to rising expenditures on medications and a surge in prescription filings worldwide. Despite this upward trend, transparency issues surrounding business models remain a significant concern within the pharmaceutical benefit management sector. Stakeholders are increasingly aware of the need for clarity and accountability in these services, which may hinder market growth. Addressing these transparency challenges is essential for fostering trust among consumers and healthcare providers, ultimately impacting the overall landscape of pharmacy benefit management. Balancing expansion with the need for transparent practices will be crucial for the market's sustainable development.

Market Trends of the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management (PBM) market is experiencing a notable shift towards the integration of machine learning technologies, driving improvements in operational efficiency and service delivery. As insurance companies, retail pharmacy chains, and drug manufacturers increasingly adopt PBM services, providers are transitioning from conventional workflows to advanced, automated processes. This transformation enables streamlined supply chains and expedited mail order deliveries, allowing companies to service a broader range of clients promptly. The adoption of machine learning enhances decision-making capabilities, optimizes cost management, and ultimately elevates the quality of healthcare provision, positioning PBM as a vital component in the evolving pharmaceutical landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Pharmacy Benefit Management Market Size by Services & CAGR (2026-2033)

  • Market Overview
  • Pharmacy Services
    • Specialty Pharmacy
    • Mail Order Pharmacies
    • Retail Pharmacies
    • Other Services
  • Drug Management
    • Drug Formulary Management
    • Benefit Plan Design

Global Pharmacy Benefit Management Market Size by Business Models & CAGR (2026-2033)

  • Market Overview
  • Pharmacy Benefit Management
    • PBM Organizations
  • Employer Programs
    • Employer-Sponsored Programs
  • Government Programs
    • Government Health Programs

Global Pharmacy Benefit Management Market Size by End Users & CAGR (2026-2033)

  • Market Overview
  • Healthcare Providers
  • Consumers
  • Other End Users

Global Pharmacy Benefit Management Market Size & CAGR (2026-2033)

  • North America (Services, Business Models, End Users)
    • US
    • Canada
  • Europe (Services, Business Models, End Users)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Services, Business Models, End Users)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Services, Business Models, End Users)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Services, Business Models, End Users)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Express Scripts Holding Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CVS Health Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OptumRx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prime Therapeutics LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Humana Pharmacy Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedImpact Healthcare Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cigna Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aetna Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anthem, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UnitedHealth Group Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WellDyneRx, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Navitus Health Solutions, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerformRx, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IngenioRx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Magellan Health, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Argus Health Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScriptCare, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Catalyst Rx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Curascript Specialty Distribution, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pharmacy Benefit Dimensions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations